1. Anti-inflammatory and anti-HIV Compounds from Swertia bimaculata. Dong, M., L.Q. Quan, W.F. Dai, S.L. Yan, C.H. Chen, X.Q. Chen, and R.T. Li. Planta Medica, 2017. 83(17): p. 1368-1373. PMID[28662527].
[PubMed]. HIV_12_2017.
2. Reversing HIV Latency via Sphingosine-1-phosphate Receptor 1 Signaling. Duquenne, C., S. Gimenez, A. Guigues, B. Viala, C. Boulouis, C. Mettling, D. Maurel, N. Campos, E. Doumazane, L. Comps-Agrar, J. Tazi, L. Prezeau, C. Psomas, P. Corbeau, and V. Francois. AIDS, 2017. 31(18): p. 2443-2454. PMID[28926402].
[PubMed]. HIV_12_2017.
3. Diaryl ethers with Carboxymethoxyphenacyl Motif as Potent HIV-1 Reverse Transcriptase Inhibitors with Improved Solubility. Fraczek, T., R. Kaminski, A. Krakowiak, E. Naessens, B. Verhasselt, and P. Paneth. Journal of Enzyme Inhibition and Medicinal Chemistry, 2017. 33(1): p. 9-16. PMID[29098886].
[PubMed]. HIV_12_2017.
4. Novel Mechanisms to Inhibit HIV Reservoir Seeding Using Jak Inhibitors. Gavegnano, C., J.H. Brehm, F.P. Dupuy, A. Talla, S.P. Ribeiro, D.A. Kulpa, C. Cameron, S. Santos, S.J. Hurwitz, V.C. Marconi, J.P. Routy, L. Sabbagh, R.F. Schinazi, and R.P. Sekaly. Plos Pathogens, 2017. 13(12): p. e1006740. PMID[29267399].
[PubMed]. HIV_12_2017.
5. Design, Synthesis, Biological Evaluation, and X-ray Studies of HIV-1 Protease Inhibitors with Modified P2' Ligands of Darunavir. Ghosh, A.K., W.S. Fyvie, M. Brindisi, M. Steffey, J. Agniswamy, Y.F. Wang, M. Aoki, M. Amano, I.T. Weber, and H. Mitsuya. ChemMedChem, 2017. 12(23): p. 1942-1952. PMID[29110408].
[PubMed]. HIV_12_2017.
6. Novel Elvitegravir Nanoformulation Approach to Suppress the Viral Load in HIV-infected Macrophages. Gong, Y., P. Chowdhury, N.M. Midde, M.A. Rahman, M.M. Yallapu, and S. Kumar. Biochemistry and Biophysics Reports, 2017. 12: p. 214-219. PMID[29214223]. PMCID[PMC5704044].
[PubMed]. HIV_12_2017.
7. Synthesis and Biological Assessment of 3,7-Dihydroxytropolones. Hirsch, D.R., D.V. Schiavone, A.J. Berkowitz, L.A. Morrison, T. Masaoka, J.A. Wilson, E. Lomonosova, H. Zhao, B.S. Patel, S.H. Datla, S.G. Hoft, S.J. Majidi, R.K. Pal, E. Gallicchio, L. Tang, J.E. Tavis, S.F.J. Le Grice, J.A. Beutler, and R.P. Murelli. Organic & Biomolecular Chemistry, 2017. 16(1): p. 62-69. PMID[29098212]. PMCID[PMC5748270].
[PubMed]. HIV_12_2017.
8. Design, Synthesis and Biological Evaluations of N-hydroxy Thienopyrimidine-2,4-diones as Inhibitors of HIV Reverse Transcriptase-associated RNase H.Kankanala, J., K.A. Kirby, A.D. Huber, M.C. Casey, D.J. Wilson, S.G. Sarafianos, and Z. Wang. European Journal of Medicinal Chemistry, 2017. 141: p. 149-161. PMID[29031062]. PMCID[PMC5682218].
[PubMed]. HIV_12_2017.
9. Exploration of Broadly Neutralizing Antibody Fragments Produced in Bacteria for the Control of HIV. Lloyd, S.B., K.P. Niven, B.R. Kiefel, D.C. Montefiori, A. Reynaldi, M.P. Davenport, S.J. Kent, and W.R. Winnall. Human Vaccines & Immunotherapeutics, 2017. 13(11): p. 2726-2737. PMID[28949787]. PMCID[PMC5703365].
[PubMed]. HIV_12_2017.
10. BET Inhibitors RVX-208 and PFI-1 Reactivate HIV-1 from Latency. Lu, P., Y. Shen, H. Yang, Y. Wang, Z. Jiang, X. Yang, Y. Zhong, H. Pan, J. Xu, H. Lu, and H. Zhu. Scientific Reports, 2017. 7(16646): 12pp. PMID[29192216]. PMCID[PMC5709369].
[PubMed]. HIV_12_2017.
11. Soybean-derived Bowman-Birk Inhibitor (BBI) Blocks HIV Entry into Macrophages. Ma, T.C., L. Guo, R.H. Zhou, X. Wang, J.B. Liu, J.L. Li, Y. Zhou, W. Hou, and W.Z. Ho. Virology, 2018. 513: p. 91-97. PMID[29040829].
[PubMed]. HIV_12_2017.
12. Isatin Thiazoline Hybrids as Dual Inhibitors of HIV-1 Reverse Transcriptase. Meleddu, R., S. Distinto, A. Corona, E. Tramontano, G. Bianco, C. Melis, F. Cottiglia, and E. Maccioni. Journal of Enzyme Inhibition and Medicinal Chemistry, 2017. 32(1): p. 130-136. PMID[27766892].
[PubMed]. HIV_12_2017.
13. MIV-150 and Zinc acetate Combination Provides Potent and Broad Activity against HIV-1. Mizenina, O., M. Hsu, N. Jean-Pierre, M. Aravantinou, K. Levendosky, G. Paglini, T.M. Zydowsky, M. Robbiani, and J.A. Fernandez-Romero. Drug Delivery and Translational Research, 2017. 7(6): p. 859-866. PMID[28812250].
[PubMed]. HIV_12_2017.
14. New Anionic Carbosilane Dendrons Functionalized with a DO3A Ligand at the Focal Point for the Prevention of HIV-1 Infection. Moreno, S., D. Sepulveda-Crespo, F.J. de la Mata, R. Gomez, and M.A. Munoz-Fernandez. Antiviral Research, 2017. 146: p. 54-64. PMID[28827122].
[PubMed]. HIV_12_2017.
15. Methoxyflavones from Marcetia taxifolia as HIV-1 Reverse Transcriptase Inhibitors. Ortega, J.T., M.L. Serrano, A.I. Suarez, J. Baptista, F.H. Pujol, and H.R. Rangel. Natural Product Communications, 2017. 125(11): p. 1677-1680. ISI[000417552000003].
[WOS]. HIV_12_2017.
16. Quiescence Promotes Latent HIV Infection and Resistance to Reactivation from Latency with Histone Deacetylase Inhibitors. Painter, M.M., T.D. Zaikos, and K.L. Collins. Journal of Virology, 2017. 91(24): p. e01080-01017. PMID[29021396]. PMCID[PMC5709582].
[PubMed]. HIV_12_2017.
17. Application of the Morita-Baylis-Hillman Reaction in the Synthesis of 3-[(N-Cycloalkylbenzamido)methyl]-2-quinolones as Potential HIV-1 Integrase Inhibitors. Sekgota, K.C., S. Majumder, M. Isaacs, D. Mnkandhla, H.C. Hoppe, S.D. Khanye, F.H. Kriel, J. Coates, and P.T. Kaye. Bioorganic Chemistry, 2017. 75: p. 310-316. PMID[29080495].
[PubMed]. HIV_12_2017.
18. Macromolecular Antiviral Agents against Zika, Ebola, SARS, and Other Pathogenic Viruses. Schandock, F., C.F. Riber, A. Rocker, J.A. Muller, M. Harms, P. Gajda, K. Zuwala, A.H.F. Andersen, K.B. Lovschall, M. Tolstrup, F. Kreppel, J. Munch, and A.N. Zelikin. Advanced Healthcare Materials, 2017. 6(23). PMID[28945945].
[PubMed]. HIV_12_2017.
19. Design, Synthesis, and Biological Activity of Novel Octahydro-1H-pyrrolo[3,2-c]pyridine Derivatives as C-C Chemokine Receptor Type 5 (CCR5) Antagonists. Wang, Y.J., U. Halambage, C.C. Zeng, and L.M. Hu. Chinese Journal of Organic Chemistry, 2017. 37(9): p. 2385-2391. ISI[000416526800021].
[WOS]. HIV_12_2017.
20. Synthesis and Biological Evaluation of Water-soluble Derivatives of Chiral Gossypol as HIVFusion Inhibitors Targeting gp41. Yang, J., L.L. Li, J.R. Li, J.X. Yang, F. Zhang, G. Chen, R. Yu, W.J. Ouyang, and S.W. Wu. Bioorganic & Medicinal Chemistry Letters, 2018. 28(1): p. 49-52. PMID[29162455].
[PubMed]. HIV_12_2017.
21. Oxazole-containing Diterpenoids from Cell Cultures of Salvia miltiorrhiza and their anti-HIV-1 Activities. Zhang, D., J. Guo, M. Zhang, X. Liu, M. Ba, X. Tao, L. Yu, Y. Guo, and J. Dai. Journal of Natural Products, 2017. 80(12): p. 3241-3246. PMID[29185738].
[PubMed]. HIV_12_2017.
Patent Citations
22. Ritonavir Selenazole Derivative with anti-HIV-1 Activity and Its Synthesis Method. Du, Y. and J. Qiao. Patent. 2017. 2017-10721786 107474045: 7pp.
[Patent]. HIV_12_2017.